Get started
BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD)BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD)BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD)

BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD)

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

0QNA chart

Key stats

Market capitalization
‪501.87 M‬CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
79.40
Basic EPS (TTM)
0.90CHF
Net income
‪10.45 M‬CHF
Revenue
‪157.63 M‬CHF
Shares float
‪11.00 M‬
Beta (1Y)
0.56

About BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD)

Sector
Health Technology
CEO
David Veitch
Headquarters
Allschwil
Website
basilea.com
Employees (FY)
147
Founded
2000
ISIN
CH0011432447
FIGI
BBG00NRVXXQ4
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000, and is headquartered in Allschwil, Switzerland.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0QNA is 40.75 CHF — it has decreased by 2.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) stocks are traded under the ticker 0QNA.
BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
0QNA stock is 2.95% volatile and has beta coefficient of 0.56. Check out the list of the most volatile stocks — is BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) there?
One year price forecast for BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) has a max estimate of 94.00 CHF and a min estimate of 52.00 CHF.
0QNA earnings for the last quarter are 2.42 CHF per share, whereas the estimation was 0.81 CHF resulting in a 200.62% surprise. The estimated earnings for the next quarter are −2.01 CHF per share. See more details about BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) earnings.
BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) revenue for the last quarter amounts to ‪84.90 M‬ CHF despite the estimated figure of ‪64.73 M‬ CHF. In the next quarter revenue is expected to reach ‪71.93 M‬ CHF.
Yes, you can track BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) financials in yearly and quarterly reports right on TradingView.
0QNA stock has fallen by 0.49% compared to the previous week, the month change is a 17.10% rise, over the last year BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) has showed a 7.70% decrease.
0QNA net income for the last quarter is ‪−21.39 M‬ CHF, while the quarter before that showed ‪31.84 M‬ CHF of net income which accounts for −167.18% change. Track more BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) financial stats to get the full picture.
Today BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) has the market capitalization of ‪503.54 M‬, it has increased by 10.74% over the last week.
No, 0QNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0QNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) stock right from TradingView charts — choose your broker and connect to your account.
0QNA reached its all-time high on Feb 12, 2021 with the price of 61.95 CHF, and its all-time low was 29.50 CHF and was reached on Mar 16, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 147.00 employees. See our rating of the largest employees — is BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) stock shows the neutral signal. See more of BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) future price: according to them, 0QNA price has a max estimate of 94.00 CHF and a min estimate of 52.00 CHF. Read a more detailed BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) forecast: see what analysts think of BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) EBITDA is ‪22.68 M‬ CHF, and current EBITDA margin is 14.39%. See more stats in BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) financial statements.